MarketPulse

bispecific antibodies

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Bispecific Antibodies Poised for $60B Market by 2031 as 550+ Trials Reshape Therapeutics

Bispecific antibody market projected to reach $60 billion by 2031 from $16 billion in 2025, with 550+ clinical trials and 18 approved drugs driving sector transformation.
AMGNJNJPFEABBVRHHBY+3clinical trialsautoimmune diseases
BenzingaBenzinga··Vandana Singh

Telix Pharma Surges on $2.14B Regeneron Deal for Solid Tumor Radiotherapies

Telix Pharma secures $2.14B partnership with Regeneron for solid tumor radiopharmaceuticals while reporting 11% quarterly revenue growth and FDA acceptance of brain cancer imaging application.
TLXREGNFDA approvalsolid tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

CTLA-4 Inhibitor Pipeline Expands With 50+ Candidates in Development Across 40+ Companies

Over 40 companies develop 50+ CTLA-4 inhibitor candidates for cancer immunotherapy. Recent FDA approvals and focus on combination strategies drive pipeline expansion.
BMYCELGrAZNIVBIYAGEN+1FDA approvalclinical trials